Fairfield House Healthcare Limited 05427029 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is that of residential care. Digita Accounts Production Advanced 6.30.9574.0 true true 05427029 2024-07-01 2025-06-30 05427029 2025-06-30 05427029 core:CurrentFinancialInstruments 2025-06-30 05427029 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 05427029 core:Non-currentFinancialInstruments core:AfterOneYear 2025-06-30 05427029 core:Goodwill 2025-06-30 05427029 core:FurnitureFittingsToolsEquipment 2025-06-30 05427029 core:LandBuildings 2025-06-30 05427029 core:MotorVehicles 2025-06-30 05427029 bus:SmallEntities 2024-07-01 2025-06-30 05427029 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 05427029 bus:FilletedAccounts 2024-07-01 2025-06-30 05427029 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 05427029 bus:RegisteredOffice 2024-07-01 2025-06-30 05427029 bus:Director1 2024-07-01 2025-06-30 05427029 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 05427029 bus:Agent1 2024-07-01 2025-06-30 05427029 core:Goodwill 2024-07-01 2025-06-30 05427029 core:FurnitureFittingsToolsEquipment 2024-07-01 2025-06-30 05427029 core:LandBuildings 2024-07-01 2025-06-30 05427029 core:MotorCars 2024-07-01 2025-06-30 05427029 core:MotorVehicles 2024-07-01 2025-06-30 05427029 countries:EnglandWales 2024-07-01 2025-06-30 05427029 2024-06-30 05427029 core:Goodwill 2024-06-30 05427029 core:FurnitureFittingsToolsEquipment 2024-06-30 05427029 core:LandBuildings 2024-06-30 05427029 core:MotorVehicles 2024-06-30 05427029 2023-07-01 2024-06-30 05427029 2024-06-30 05427029 core:CurrentFinancialInstruments 2024-06-30 05427029 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 05427029 core:Non-currentFinancialInstruments core:AfterOneYear 2024-06-30 05427029 core:FurnitureFittingsToolsEquipment 2024-06-30 05427029 core:LandBuildings 2024-06-30 05427029 core:MotorVehicles 2024-06-30 iso4217:GBP xbrli:pure

Registration number: 05427029

Prepared for the registrar
Fairfield House Healthcare Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 30 June 2025

Fairfield House Healthcare Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 8

Fairfield House Healthcare Limited

Company Information

Director | Z D Hutchins

Registered office | Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Accountants | Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Fairfield House Healthcare Limited

(Registration number: 05427029)
Balance Sheet as at 30 June 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | - | -
Tangible assets | 5 | 1,890,674 | 1,902,105
| 4 | 1,890,674 | 1,902,105
Current assets |  |  |
Stocks | 6 | 1,000 | 1,000
Debtors | 7 | 79,442 | 61,910
Debtors: Amounts falling due after more than one year |  | 678,101 | 496,675
Cash at bank and in hand |  | 342,154 | 574,489
|  | 1,100,697 | 1,134,074
Creditors: Amounts falling due within one year | 8 | (130,683) | (203,099)
Net current assets |  | 970,014 | 930,975
Total assets less current liabilities |  | 2,860,688 | 2,833,080
Creditors: Amounts falling due after more than one year | 8 | (1,354,812) | (1,393,543)
Deferred tax liabilities |  | - | (1,150)
Net assets |  | 1,505,876 | 1,438,387
Capital and reserves |  |  |
Called up share capital |  | 1,000 | 1,000
Retained earnings |  | 1,504,876 | 1,437,387
Shareholders' funds |  | 1,505,876 | 1,438,387

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 24 March 2026

Z D Hutchins
Director

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

| 1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

| 2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of returns, rebates and discounts and after eliminating sales within the company.The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures, fittings and equipment | 15% straight line
Motor vehicles | 20% straight line

No depreciation is provided on freehold property as it is the company's policy to maintain the property so that it keeps its previously assessed standard of performance. As the useful economic life of this class of asset is of such length and the residual value is such that it is not materially different from the carrying amount, any depreciation would not be material.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.
Negative goodwill arising on an acquisition is recognised on the face of the balance sheet on the acquisition date and subsequently the excess up to the fair value of non-monetary assets acquired is recognised in profit or loss in the periods in which the non-monetary assets are recovered.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | 10 years straight line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.
The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

| 3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

| 2025 No. | 2024 No.
Average number of employees | 36 | 40

| 4 | Intangible assets

| Goodwill £
Cost
At 1 July 2024 and at 30 June 2025 | 770,000
Amortisation
At 1 July 2024 and at 30 June 2025 | 770,000
Carrying amount
At 30 June 2024 and at 30 June 2025 | -

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

| 5 | Tangible assets

| Land and buildings £ | Fixtures, fittings and equipment £ | Motor vehicles £ | Total £
Cost
At 1 July 2024 | 1,854,142 | 531,702 | 17,200 | 2,403,044
Additions | - | 5,545 | - | 5,545
At 30 June 2025 | 1,854,142 | 537,247 | 17,200 | 2,408,589
Depreciation
At 1 July 2024 | - | 483,739 | 17,200 | 500,939
Charge for the year | - | 16,976 | - | 16,976
At 30 June 2025 | - | 500,715 | 17,200 | 517,915
Carrying amount
At 30 June 2025 | 1,854,142 | 36,532 | - | 1,890,674
At 30 June 2024 | 1,854,142 | 47,963 | - | 1,902,105

| 6 | Stocks

| 2025 £ | 2024 £
Raw materials and consumables | 1,000 | 1,000

| 7 | Debtors

| 2025 £ | 2024 £
Trade debtors | 66,519 | 54,465
Amounts owed by related parties | 678,101 | 496,675
Other debtors | 5,571 | 5,000
Prepayments | 5,865 | 2,445
Deferred tax assets | 1,487 | -
| 757,543 | 558,585
Less non-current portion | (678,101) | (496,675)
| 79,442 | 61,910

Details of non-current trade and other debtors

£678,101 (2024- £496,675) of amounts owed by related parties is classified as non-current.

Fairfield House Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

| 8 | Creditors

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 27,354 | 43,124
Social security and other taxes | 17,452 | 14,767
Outstanding defined contribution pension costs | 3,342 | 3,107
Other creditors | 31,313 | 37,616
Accrued expenses | 34,430 | 7,001
Corporation tax liability | 16,792 | 97,484
| 130,683 | 203,099
Due after one year |  |
Amounts owed by related parties | 1,354,812 | 1,393,543